Intraperitoneal and Intravenous Paclitaxel Chemotherapy With Oral Capecitabine for Gastric Adenocarcinoma With Peritoneal Carcinomatosis

Stopped Scientific reprioritization. Closed per principal investigator discretion to prioritize enrollment in another study.

Conditions

• Gastric Adenocarcinoma
• Gastric Cancer
• Esophagogastric Junction
• Peritoneal Carcinomatosis

Interventions

• DRUG: Paclitaxel
• DRUG: Capecitabine
• DEVICE: BardPort Titanium Implanted Port with Peritoneal Catheter

Sponsor

National Cancer Institute (NCI)